Increase In Clinical Trials For Pigment Glaucoma In Global Market Outlook: Ken Research

1
Increase In Clinical Trials For Pigment Glaucoma
In Global Market Outlook Ken Research
2

• 
  Summary
• Global Data's clinical trial report, Pigment
  Glaucoma Global Clinical Trials Review, H1, 2018
  provides an overview of Pigment Glaucoma clinical
  trials scenario. This report provides top line
  data relating to the clinical trials on Pigment
  Glaucoma. Report includes an overview of trial
  numbers and their average enrollment in top
  countries conducted across the globe.

3

• - According to the report analysis, Pigment
  Glaucoma Global Clinical Trials Review, H1, 2018
  suggests that some of the major companies and
  health organizations are functioning in this for
  doing the efficient treatment of the pigment
  glaucoma such as novartis, agallergan, plc
  clinuvel pharmaceuticals ltd, valeant
  pharmaceuticals international inc, pharmaceutical
  co ltd.
• Anderson cancer center, wyeth pharmaceuticals
  inc., ge healtcare, Columbia university,
  vanderbilt medical center, bristol-myers squib
  company, copharos inc., national cancer center,
  bayer ag, mayo clinic, duke university,
  university of pennsylvania, duke university and
  others. Moreover, the organizations are working
  very efficiently for solving the problem of
  pigment with the more experiments and the
  development in the instruments.

4

• Pigmentary Glaucoma is a type of assumed
  open-angle glaucoma which develops more
  frequently in men than in women. Pigment glaucoma
  is the discharge of pigment from the posterior
  aspect of the iris into the anterior segment
  following the flow of melting humor. Pigment
  glaucoma is commonly presents between the second
  and forth decades, which is earlier than other
  types of glaucoma.
• Pigment glaucoma can result to significant damage
  to the drain and elevate eye pressure. By the
  time, the elevated eye pressure can damage the
  optic nerve and causing pigmentary glaucoma.
  Whereas, the untreated glaucoma can result to
  loss of vision and become worsen such as lead to
  complete blindness. Geographically, the
  Asia-pacific region, Europe, north America,
  middle east and Africa, central and South America
  shows the frequentness in the treatment of the
  pigment glaucoma.

5

• The treatment of pigment glaucoma includes
  minoring pressure using surgery, laser or
  medications. Unfortunately, it is very difficult
  to lessen or eliminate the release of iris
  pigment.
• Hence, more observation is focused on reducing
  eye pressure. Not only has this, patients of
  pigmentary glaucoma can be treated successfully
  and thankfully, with the development in the
  modern treatments, many victims are able to
  maintain excellent vision. With the dangerous
  cause of vision loss many key players are working
  very effectively, they started making eye drops
  for resolving the problem and doing great job in
  the treatment with enhanced technologies.
  Therefore, the future of these clinical trials is
  expected to be bright in the coming years.

6

• Browse Full Market Report
• Pigment Glaucoma Global Clinical Trials Review,
  H1, 2018
• Related reports
• Open-Angle Glaucoma Global Clinical Trials
  Review, H1, 2018
• EpiCast Report Glaucoma-Epidemiology Forecast to
  2026

7
About Ken Research

• Ken Research provides bespoke industry
  intelligence, equity research reports and
  business consulting services on gamut of sectors
  across the globe. We use advanced information
  management tools, sophisticated analytical
  systems and methodologies to help our clients
  with crucial industry information for decision
  making.
• As a leading Online Market Research Report
  Seller, Ken Research act as a platform for
  accessing statistics, forecast, business
  insights, Ideas, concepts and much more.

8

• Contact Us
• Ken Research
• Ankur Gupta, Head Marketing Communications
• sales_at_kenresearch.com
• 91-9015378249

9
(No Transcript)